{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-25-000031","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2025-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.823383+00:00","generated_at":"2026-05-26T23:58:58.577463+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"BioRestorative Therapies presents at ORS 2025; VP Silva discusses development programs","bullets":["Francisco Silva, VP of R&D, presented at Orthopaedic Research Society 2025 Annual Meeting on Feb 8.","Presentation materials will be posted on company website for 90 days under Scientific Publications.","No financial or clinical results from the presentation disclosed in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-25-000031","json":"https://secwatch.observer/filing/0001021771-25-000031.json","markdown":"https://secwatch.observer/filing/0001021771-25-000031.md","text":"https://secwatch.observer/filing/0001021771-25-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000031/0001021771-25-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000031/brt8k21025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:58:58.577463+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}